Skeletal Optimization of Cytotoxic Lipidic Dialkynylcarbinols

ChemMedChem. 2018 Jun 6;13(11):1124-1130. doi: 10.1002/cmdc.201800118. Epub 2018 Apr 26.

Abstract

In line with a recent study of the pharmacological potential of bioinspired synthetic acetylenic lipids, after identification of the terminal dialkynylcarbinol (DAC) and butadiynyl alkynylcarbinol (BAC) moieties as functional antitumor pharmacophoric units, this work specifically addresses the issue of carbon backbone length. A systematic variation of the aliphatic chain length was thus carried out in both the DAC and BAC series. The critical impact of the length of the lipidic skeleton was first confirmed in the racemic series, with the highest cytotoxic activity observed for C17 to C18 backbones. Enantiomerically enriched samples were prepared by asymmetric synthesis of the optimal C18 DAC and C17 BAC derivatives. Samples with upgraded enantiomeric purity were alternatively produced by enzymatic kinetic resolution. Eutomers possessing the S configuration displayed cytotoxicity IC50 values as low as 15 nm against HCT116 cancer cells, the highest level of activity reached to date in this series.

Keywords: alkynols; asymmetric synthesis; cytotoxicity; enzymatic kinetic resolution; marine lipids; polyacetylenes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / chemical synthesis
  • Alkynes / chemistry
  • Alkynes / pharmacology*
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Fatty Alcohols / chemical synthesis
  • Fatty Alcohols / chemistry
  • Fatty Alcohols / pharmacology*
  • HCT116 Cells
  • Humans
  • Molecular Structure
  • Stereoisomerism

Substances

  • Alkynes
  • Antineoplastic Agents
  • Fatty Alcohols